These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 19736635

  • 1. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
    Vítovec M, Golán L, Roztocil K, Linhart A.
    Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M, Koksoy C, Hasan E, Akcalı Y, Karabay O, Filizcan U, TROMBOTEK Study Group.
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Nov; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G, Mani V, Goldhaber SZ, Grosso MA, Mercuri M, Lanz HJ, Schussler S, Hsu C, Chinigo A, Ritchie B, Nadar V, Cannon K, Pullman J, Concha M, Schul M, Fayad ZA, edoxaban Thrombus Reduction Imaging Study (eTRIS) Investigators.
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK.
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deep vein thrombosis outcome and the level of oral anticoagulation therapy.
    Caprini JA, Arcelus JI, Reyna JJ, Motykie GD, Mohktee D, Zebala LP, Cohen EB.
    J Vasc Surg; 1999 Nov; 30(5):805-11. PubMed ID: 10550177
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat-Bouvet L, Labourey JL, Martin J, Slaouti P, Tubiana-Mathieu N.
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [Abstract] [Full Text] [Related]

  • 16. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
    Vorob'eva NM, Panchenko EP, Dobrovol'skiĭ AB, Titaeva EV, Ermolina OV, Balakhonova TV, Kirienko AI.
    Angiol Sosud Khir; 2010 Jul; 17(1):87-94. PubMed ID: 21780625
    [Abstract] [Full Text] [Related]

  • 17. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
    Chitsike RS, Rodger MA, Kovacs MJ, Betancourt MT, Wells PS, Anderson DR, Chagnon I, LE Gal G, Solymoss S, Crowther MA, Perrier A, White RH, Vickars LM, Ramsay T, Kahn SR.
    J Thromb Haemost; 2012 Oct; 10(10):2039-44. PubMed ID: 22846068
    [Abstract] [Full Text] [Related]

  • 18. Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study.
    Vucić N, Ostojić R, Svircić T.
    Croat Med J; 2002 Jun; 43(3):296-300. PubMed ID: 12035135
    [Abstract] [Full Text] [Related]

  • 19. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS, THRIVE Treatment Study Investigators.
    JAMA; 2005 Feb 09; 293(6):681-9. PubMed ID: 15701909
    [Abstract] [Full Text] [Related]

  • 20. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S, Malato A, Saccullo G, Iorio A, Di Ianni M, Caracciolo C, Coco LL, Raso S, Santoro M, Guarneri FP, Tuttolomondo A, Pinto A, Pepe I, Casuccio A, Abbadessa V, Licata G, Battista Rini G, Mariani G, Di Fede G.
    Am J Hematol; 2011 Nov 09; 86(11):914-7. PubMed ID: 21953853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.